Jason Michael Nolan

Array ( [id] => 4966010 [patent_doc_number] => 20080108830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Production method of optically active 2-[(N-benzylprolyl)amino]benzo-phenone compound' [patent_app_type] => utility [patent_app_number] => 11/979108 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4331 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108830.pdf [firstpage_image] =>[orig_patent_app_number] => 11979108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4966006 [patent_doc_number] => 20080108826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'PREPARATION OF 4-ALKOXY-7-(TETRAHYDRO-PYRAN-4-YL)-BENZOTHIAZOL-2-YLAMINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/926787 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4904 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108826.pdf [firstpage_image] =>[orig_patent_app_number] => 11926787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558900 [patent_doc_number] => 20090270477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'POLYMORPHS OF A HYDROISOINDOLINE TACHYKININ RECEPTOR ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 12/446996 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8150 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270477.pdf [firstpage_image] =>[orig_patent_app_number] => 12446996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310806 [patent_doc_number] => 20090018087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Novel Inhibitors of Glutaminyl Cyclase' [patent_app_type] => utility [patent_app_number] => 11/923307 [patent_app_country] => US [patent_app_date] => 2007-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27672 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018087.pdf [firstpage_image] =>[orig_patent_app_number] => 11923307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753505 [patent_doc_number] => 20080161581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'SYNTHETIC METHODOLOGY FOR THE REDUCTIVE ALKYLATION AT THE C-3 POSITION OF INDOLES' [patent_app_type] => utility [patent_app_number] => 11/872193 [patent_app_country] => US [patent_app_date] => 2007-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4446 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161581.pdf [firstpage_image] =>[orig_patent_app_number] => 11872193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 63250 [patent_doc_number] => 07763735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-27 [patent_title] => 'Synthesis of enone intermediate' [patent_app_type] => utility [patent_app_number] => 11/870772 [patent_app_country] => US [patent_app_date] => 2007-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 31528 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/763/07763735.pdf [firstpage_image] =>[orig_patent_app_number] => 11870772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196953 [patent_doc_number] => 07638548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Spiroindolinone derivatives' [patent_app_type] => utility [patent_app_number] => 11/867155 [patent_app_country] => US [patent_app_date] => 2007-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11636 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638548.pdf [firstpage_image] =>[orig_patent_app_number] => 11867155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356011 [patent_doc_number] => 20100022528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'TETRA-SUBSTITUTED NDGA DERIVATIVES VIA ETHER BONDS AND CARBAMATE BONDS AND THEIR SYNTHESIS AND PHARMACEUTICAL USE' [patent_app_type] => utility [patent_app_number] => 12/443906 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22287 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022528.pdf [firstpage_image] =>[orig_patent_app_number] => 12443906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693155 [patent_doc_number] => 20080085926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 11/906374 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23309 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11906374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922652 [patent_doc_number] => 20080070969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => '[3.2.0] HETEROCYCLIC COMPOUNDS AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/865704 [patent_app_country] => US [patent_app_date] => 2007-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 42293 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070969.pdf [firstpage_image] =>[orig_patent_app_number] => 11865704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627562 [patent_doc_number] => 20100004158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/443746 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23310 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004158.pdf [firstpage_image] =>[orig_patent_app_number] => 12443746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6224003 [patent_doc_number] => 20100056788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'FLUOROBORON COMPOUND HAVING AROMATIC RING OR SALT THEREOF, AND METHOD FOR PRODUCING COMPOUND HAVING CYCLIC ETHER-FUSED AROMATIC RING USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/440557 [patent_app_country] => US [patent_app_date] => 2007-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14073 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056788.pdf [firstpage_image] =>[orig_patent_app_number] => 12440557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5289934 [patent_doc_number] => 20090022664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Radiolabelling via fluorination of aziridines' [patent_app_type] => utility [patent_app_number] => 11/851786 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23829 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022664.pdf [firstpage_image] =>[orig_patent_app_number] => 11851786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445560 [patent_doc_number] => 20100144721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'INHIBITORS OF C-MET AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/438995 [patent_app_country] => US [patent_app_date] => 2007-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14276 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144721.pdf [firstpage_image] =>[orig_patent_app_number] => 12438995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728187 [patent_doc_number] => 20080207731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => '3-(3-INDOLYL) PROPIONIC ACID CALCIUM SALT AND METHOD OF MAKING 3-(3-INDOLYL) PROPIONIC ACID FREE ACID THEREFROM' [patent_app_type] => utility [patent_app_number] => 11/843836 [patent_app_country] => US [patent_app_date] => 2007-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6956 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207731.pdf [firstpage_image] =>[orig_patent_app_number] => 11843836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085895 [patent_doc_number] => 20070275946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Cytokine Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/839136 [patent_app_country] => US [patent_app_date] => 2007-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19460 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275946.pdf [firstpage_image] =>[orig_patent_app_number] => 11839136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8470091 [patent_doc_number] => 08299270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Clay modified electrolyte for a dye-sensitized solar cell' [patent_app_type] => utility [patent_app_number] => 12/377397 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7548 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12377397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6466445 [patent_doc_number] => 20100040547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'DYES AND PRECURSORS AND CONJUGATES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/376225 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7069 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040547.pdf [firstpage_image] =>[orig_patent_app_number] => 12376225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53668 [patent_doc_number] => 07772409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Method of preparing sultines' [patent_app_type] => utility [patent_app_number] => 11/831963 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6643 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772409.pdf [firstpage_image] =>[orig_patent_app_number] => 11831963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4651020 [patent_doc_number] => 20080038276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'INHIBITORS OF PLASMA KALLIKREIN' [patent_app_type] => utility [patent_app_number] => 11/830539 [patent_app_country] => US [patent_app_date] => 2007-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14225 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038276.pdf [firstpage_image] =>[orig_patent_app_number] => 11830539 [rel_patent_id] =>[rel_patent_doc_number] =>)